Compare the best cancer screening tests available in United Kingdom. 32 tests reviewed.
Priced close to the FIT test group median
A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.
Broadest package for women, at a premium price
The Female Cancer Risk package plus added heart-focused checks: an ECG, peripheral arterial disease test, Lipoprotein(a) and a heart disease and stroke risk assessment.
Broadest package for men, at a premium price
The Male Cancer Risk package plus added heart-focused checks: an ECG, peripheral arterial disease test, Lipoprotein(a) and a heart disease and stroke risk assessment.
Women's cancer-risk screen adding an HPV cervical test
A wide cancer-risk and general health screen for women over 40, covering bowel, cervical and stomach cancer risk markers alongside liver, kidney, thyroid and immune function.
Men's cancer-risk screen adding a PSA prostate test
A wide cancer-risk and general health screen for men over 40, including a PSA prostate cancer risk test alongside bowel, stomach, liver, kidney and lung function checks.
Second-cheapest FIT test in the comparison group
A rapid at-home stool test for hidden blood (FIT), a marker commonly used to help assess bowel health and flag the need for further investigation.
Mid-priced qFIT test, near the group median
A stool-based qFIT test that checks for hidden blood in your stool, often used to help investigate bowel symptoms or as part of screening.
CA 125 tumour marker test, home or clinic collection
A blood test for CA 125, a protein used as a tumour marker in specific circumstances, most often associated with ovarian cancer but also raised by non-cancerous conditions.
CA 19-9 monitoring marker, not a screening test
A blood test for CA 19-9, a tumour marker used alongside other investigations to monitor a known condition or treatment response, not as a stand-alone screening test.
CA 15-3 marker test, not a stand-alone cancer check
A blood test for CA 15-3, a protein sometimes raised in breast and other cancers, most often used to help track how a known cancer is responding to treatment.
Randox's broadest and most expensive test
A genetic blood test screening 112 genes linked to inherited risk of breast, ovarian, prostate, colorectal and thyroid cancers, with a doctor-reviewed consultation.
14-gene hereditary risk panel with doctor-reviewed results
This blood test analyses 14 genes associated with inherited prostate cancer risk, including BRCA1 and BRCA2, and suits men with a family history of prostate, breast or ovarian cancer.
